ArticleThe Journal of biological chemistry2013

Improving antigenic peptide vaccines for cancer immunotherapy using a dominant tumor-specific T cell receptor.

Jonathan D Buhrman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.